Francisco Rodríguez-Frías

researcher

Francisco Rodríguez-Frías is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-9128-7013
P1153Scopus author ID6701588125

P735given nameFranciscoQ7201446
FranciscoQ7201446
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q45352035A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model
Q40192872A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Q53822443Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.
Q46587742Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy
Q49514801Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population
Q45729441Applicability of real-time PCR combined with melting curve analysis for the study of hepatitis B virus genome mutations
Q37420024Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach
Q40419604Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.
Q59796469Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
Q47302853Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency
Q58861568Characterization of the New Alpha-1-Antitrypsin-Deficient PI M-Type Allele, PI M vall d’hebron (Pro 369 →Ser)
Q33961593Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection
Q34506624Clinical application of estimating hepatitis B virus quasispecies complexity by massive sequencing: correlation between natural evolution and on-treatment evolution
Q57097288Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
Q35216125Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain
Q35880685Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus
Q40682456Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods
Q58861557Cuantificación del antígeno de superficie del virus de la hepatitis B: implicaciones clínicas
Q39063756Deep sequencing in the management of hepatitis virus infections.
Q44680874Detection of hepatitis B precore mutants by the fluorescent linear polymerase chain reaction sequencing method.
Q55259180Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy.
Q42232115Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.
Q51664034Emphysema due to alpha-antitrypsin deficiency: familial study of the YBARCELONA variant.
Q58861548Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679]
Q36065068Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
Q58861564Farmacocinética de la alfa-1-antitripsina utilizada en el tratamiento sustitutivo del enfisema congénito grave
Q47141376Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency
Q45748634Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.
Q48004435Genetic diagnosis of α1-antitrypsin deficiency using DNA from buccal swab and serum samples
Q50545949HBV core region variability: effect of antiviral treatments on main epitopic regions.
Q58578646HDV evolution-will viral resistance be an issue in HDV infection?
Q34491877Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes
Q45417315Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
Q43462569Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients.
Q42173073Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin
Q58861550Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy
Q42984816Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin
Q58861576Hepatitis E infection in acute sporadic hepatitis in Spain
Q45771876Hepatitis E virus infection in acute hepatitis in Spain.
Q44996647Hepatitis E: scale of the problem in Spain
Q40335058High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping
Q28652352High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods
Q42985791IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors
Q42261817Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection
Q41923520Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology.
Q42197661Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination.
Q38229802Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update
Q38175788Inference with viral quasispecies diversity indices: clonal and NGS approaches
Q57778379Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults
Q45860637Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.
Q45374496Infrequent detection of hepatitis E virus RNA in pregnant women with hepatitis E virus antibodies in Spain
Q71699150Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis
Q43897814Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?
Q53137778Laboratory Diagnosis by Genotyping.
Q37740855Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centres.
Q58861569Letters to the Editor
Q37221506Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina
Q46575508New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors
Q40422658New real-time-PCR method to identify single point mutations in hepatitis C virus.
Q113251485Next-Generation Sequencing for Confronting Virus Pandemics
Q42230868Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion
Q58768677Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
Q38935930Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).
Q41922052Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing
Q43117100Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.
Q40987185Quasispecies dynamics in hepatitis C liver transplant recipients receiving grafts from hepatitis C virus infected donors
Q36395364Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing
Q37285249Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach
Q50886270Rapid detection of Mmalton α1-antitrypsin deficiency allele by real-time PCR and melting curves in whole blood, serum and dried blood spot samples.
Q57777929Rare alpha-1-antitrypsin variants: are they really so rare?
Q58786455Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
Q48012815Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report
Q44131409Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues
Q58861554Registro español de pacientes con déficit de alfa-1 antitripsina: evaluación de la base de datos y análisis de la población incluida
Q42208612Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification
Q42986040Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.
Q40251459Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy
Q40294468Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype
Q34325994Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid
Q58854025Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant
Q39669674Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis
Q39689447Sporadic cases of acute autochthonous hepatitis E in Spain
Q43977371Study of hepatitis B virus replication and infection by other hepatitis viruses in patients with chronic hepatitis B virus infection
Q37616336Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab
Q41163712Tenofovir discontinuation after long-term viral suppression in HBeAg negative chronic hepatitis B. Can HBsAg levels be useful?
Q37142007The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer
Q58861572The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection
Q45747052Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen.
Q101051714Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory
Q42977026Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients
Q30726364Ultra-deep pyrosequencing (UDPS) data treatment to study amplicon HCV minor variants.
Q38830111Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome
Q28484005Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome
Q43179791Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy
Q44967742Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA.
Q53085945Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.
Q35984339Viral quasispecies complexity measures.
Q58861561Virología molecular del virus de la hepatitis B
Q54379182[Diagnosis of alpha-1 antitrypsin deficiency: limitations of rapid diagnostic laboratory tests].
Q50553132[Hepatitis E: molecular virology, epidemiology and pathogenesis].
Q48778639α1-Antitrypsin in fibromyalgia: results of a randomized, placebo-controlled, double-blind and crossover pilot trial